AIMS:The rise of multidrug-resistant Acinetobacter baumannii, listed by the WHO as a top-priority pathogen, necessitates the urgent development of new antimicrobial agents. Here, we identified and evaluated halogenated catechol derivatives with potent antimicrobial and antibiofilm activity against A. baumannii and other ESKAPE pathogens. MATERIALS AND METHODS:Fifteen halogenated catechol derivatives were screened for antimicrobial activity. The most active compounds, namely tetrachlorocatechol (TCC) and tetrabromocatechol (TBC), were evaluated for their impact on biofilm formation, membrane integrity, oxidative stress induction, iron chelation, gene expression, and activity against polymicrobial biofilms. These were assessed using a combination of biochemical assays, microscopy, in-silico docking, and qRT-PCR. Structure-activity relationships (SAR) were examined, and toxicity was evaluated through hemolysis, C. elegans survival, and HepG2 cell viability assays. KEY FINDINGS:We identified TCC and TBC with MIC values of 15 and 25 μg/mL, respectively, and repressed key biofilm genes, such as pgaA, csuC. They showed potential for multifaceted antimicrobial mechanisms, including membrane disruption, oxidative stress induction, and Fe3+ chelation. Both compounds downregulated the adeB efflux pump gene and bound effectively to the AdeB transporter protein. Also, they yielded significant synergistic effects with colistin and aminoglycosides. SAR analysis indicated that multi-halogenation with chlorine or bromine enhances antimicrobial potency. Moreover, they exhibited low toxicity in preliminary models and suppressed mono- and polymicrobial biofilms involving Pseudomonas, Enterococcus, and Klebsiella species. SIGNIFICANCE:Multi-halogenated catechols represent promising antimicrobial leads with potential multi-targeted mechanisms, and reduced resistance emergence to combat A. baumannii menace.
更多